Bliss GVS Pharma Limited (BOM:506197)
India · Delayed Price · Currency is INR 510.55
+22.86 (4.69%)
At close: Jul 7, 2026
Bliss GVS Pharma Market Cap
Bliss GVS Pharma has a market cap or net worth of 54.25 billion as of July 7, 2026. Its market cap has increased by 249.55% in one year.
Market Cap
54.25B
Enterprise Value
52.97B
Revenue
9.27B
Ranking
n/a
PE Ratio
42.63
Stock Price
510.55
Market Cap Chart
Since January 11, 2002, Bliss GVS Pharma's market cap has increased from 10.05M to 54.25B, an increase of 539,627.31%. That is a compound annual growth rate of 42.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 54.25B | 213.67% |
| Dec 31, 2025 | 17.30B | -0.33% |
| Dec 31, 2024 | 17.35B | 33.41% |
| Dec 29, 2023 | 13.01B | 72.15% |
| Dec 30, 2022 | 7.56B | -29.58% |
| Dec 31, 2021 | 10.73B | -48.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CORONA Remedies | 122.57B |
| Procter & Gamble Health | 104.93B |
| Sanofi India | 79.38B |
| FDC Limited | 70.00B |
| Gufic Biosciences | 37.61B |
| Novartis India | 36.27B |
| Morepen Laboratories | 33.30B |
| Unichem Laboratories | 32.67B |